Skip to main content
. 2019 Jun 9;9(6):e029700. doi: 10.1136/bmjopen-2019-029700

Table 5.

Risk of mortality during 6 years of follow-up by the presence of specific eye diseases at baseline

No at risk Deaths Risk per 1000/6 years (95% CI) Age/sex- adjusted risk ratio
Cataract present
 No 1921 142 72.5 (59.1 to 88.6) Reference
 Yes 1478 265 181.3 (161.6 to 202.8) 1.26 (0.95 to 1.66)
Cataract and visual impairment (VI) present (<6/18)
 No 3103 313 100.7 (87.5 to 115.5) Reference
 Yes 296 94 322 (267.3 to 381.8) 1.57 (1.24 to 1.98)
Age-related macular degeneration (AMD) present
 No 2270 225 99.2 (83.3 to 117.8) Reference
 Yes 319 57 183.4 (141.3 to 234.5) 1.34 (0.99 to 1.81)
AMD and VI present (<6/18)
 No 2529 265 105.5 (89.9 to 123.4) Reference
 Yes 60 17 282.7 (178.5 to 416.8) 1.42 (0.91 to 2.22)
Diabetic retinopathy (DR) present
 No 2513 264 105.7 (90.4 to 123.3) Reference
 Yes 55 18 318.4 (199.4 to 467.0) 3.18 (1.98 to 5.09)
DR and VI present (<6/18)
 No 2563 280 109.9 (94.1 to 128.0) Reference
 Yes 5 2 401.6 (37.5 to 920.4) 2.54 (0.57 to 11.36)